Optimizing non-invasive screening to reduce biopsy screen failure in clinical trials for metabolic dysfunction-associated steatotic liver disease

Vali Y., Wonders K., Aithal G., Aller R., Allison M., Arola J., Banales JM., Bernal V., Berzigotti A., Boursier J., Brass C., Bugianesi E., Panero JLC., Cobbold J., Cortez-Pinto H., Crespo J., Davies S., Driessen A., Duffin K., Ekstedt M., Forton D., Fournier-Poizat C., Francque S., Geier A., Gouw A., Hagstroem H., Holleboom AGO., Hytiroglou P., Karsdal M., Lackner C., Leeming DJ., Magnanensi J., Mayo R., Miele L., Papatheodoridis G., Paradis V., Pavlides M., Pericas JM., Petta S., Ratziu V., Romero-Gomez M., Schattenberg JM., Schuppan D., Silva A., Kjaer M., Straub B., Svegliati-Baroni G., Tiniakos DG., Tonini MM., Torstenson R., Valenti L., Verheij J., Wenn D., Yki-Jaervinen H., Yunis C., Anstee QM., Bossuyt P.

Type

Conference paper

Publication Date

2025-01-01T00:00:00+00:00

Volume

82

Permalink Close